IRCT20170123032145N7尚未招募Unknown
Acetylcysteine (NAC) augmentation in the treatment of symptoms and cognitive function among patients with obsessive-compulsive disorder A double-blind placebo-controlled, randomized clinical trial
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients who meet DSM-5 criterion for OCD and they achieve more than 21 for Yale-Brown Obsessive Compulsive Scale are suitable for study.
- •They should be 18-65 year old
- •They should sign the consent form
排除标准
- •They should not be treated by any psychiatric interventions for last 6 weeks.
- •If they show any other important mental condition or suicidal thought, neurological deficit, will exclude from study.
- •They will be evaluated for cardiac, liver, kidney, pregnancy, lactation and mental retardation before entrance and any mentioned conditions will cause exclusion from study.
研究者
相似试验
已完成
2 期
Adjuvant N Acetylcysteine for Post Traumatuic Stress DisorderACTRN12618001784202Austin Health105
招募中
2 期
Effect of N-acetylcysteine as adjunct therapy versus placebo on clinical outcomes and serum levels of oxidative stress biomarkers in patients with systolic heart failureIRCT20120215009014N333Hamedan University of Medical Sciences80
招募中
3 期
Efficacy of N-Acetyl cysteine in patients with autism spectrum disorderAutism spectrum disorder.Childhood autismF84.0IRCT20190714044199N1Medical Science University of Mashhad66
已完成
3 期
The effectiveness of N-acetylcystein (NAC) on accelerating renal failer recoveryLeptospirosisIRCT20190727044343N4Mazandaran University of Medical Sciences64
已完成
3 期
acetylcysteine in Unipolar depressionipolar depressionUnipolar depressionMental Health - DepressionACTRN12607000134426Mental Health Research Institute120